Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 4
1960 1
1961 1
1962 3
1963 3
1964 6
1965 7
1966 3
1967 4
1968 3
1969 1
1970 3
1971 6
1972 7
1973 14
1974 13
1975 15
1976 13
1977 6
1978 10
1979 20
1980 25
1981 38
1982 24
1983 24
1984 31
1985 48
1986 65
1987 74
1988 85
1989 121
1990 116
1991 129
1992 151
1993 194
1994 217
1995 256
1996 285
1997 317
1998 348
1999 376
2000 492
2001 570
2002 788
2003 948
2004 1125
2005 1466
2006 1708
2007 1959
2008 2470
2009 2771
2010 3412
2011 3960
2012 4723
2013 5635
2014 6588
2015 7397
2016 7577
2017 8338
2018 9288
2019 10665
2020 12625
2021 14436
2022 16904
2023 16189
2024 17878
2025 6764

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151,272 results

Results by year

Filters applied: . Clear all
Page 1
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma.
Mou W, Deng Z, Zhu L, Jiang A, Lin A, Xu L, Deng G, Huang H, Guo Z, Zhu B, Wu S, Yang T, Wang L, Liu Z, Wei T, Zhang J, Cheng L, Huang H, Chen R, Shao Y, Cheng Q, Wang L, Yuan S, Luo P. Mou W, et al. Among authors: wang l. Sci Adv. 2025 Apr 11;11(15):eadu1727. doi: 10.1126/sciadv.adu1727. Epub 2025 Apr 9. Sci Adv. 2025. PMID: 40203108 Free PMC article.
Bireociclib plus fulvestrant for HR+/HER2- advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis.
Wang J, Zhang Q, Li H, Tong Z, Ouyang Q, Li H, Teng Y, Wang B, Sun T, Wang J, Li W, Niu Z, Li H, Gong C, Wang S, Wang X, Wu X, Liu N, Yu G, Liu F, Duan X, Wang S, Meng Y, Wang L, Xu B. Wang J, et al. Among authors: wang l. Nat Commun. 2025 Apr 9;16(1):3350. doi: 10.1038/s41467-025-58647-z. Nat Commun. 2025. PMID: 40204778 Free PMC article. Clinical Trial.
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers.
Chen K, Liu A, Wang C, Hu C, Chen C, Yang F, Chen H, Shen H, Zhang H, Liu H, Xiong J, Wang J, Zhang L, Xu L, Wang L, Zhao M, Li Q, Song Q, Zhou Q, Wang Q, Ma S, Xu S, Yuan S, Gao S, Lu S, Li W, Mao W, Liu X, Dong X, Yang X, Wu Y, Cheng Y, Song Y, Huang Y, Zhang Z, Chen Z, Ma Z, Zielinski CC, Shyr Y, Wang J; 7th Lung Cancer Expert Committee of China Anti-Cancer Association (CACA). Chen K, et al. Among authors: wang l. Med. 2025 Apr 11;6(4):100643. doi: 10.1016/j.medj.2025.100643. Med. 2025. PMID: 40220743 Review.
151,272 results
You have reached the last available page of results. Please see the User Guide for more information.